Your browser doesn't support javascript.
loading
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts.
Garcia-Manero, G; Sekeres, M A; Egyed, M; Breccia, M; Graux, C; Cavenagh, J D; Salman, H; Illes, A; Fenaux, P; DeAngelo, D J; Stauder, R; Yee, K; Zhu, N; Lee, J-H; Valcarcel, D; MacWhannell, A; Borbenyi, Z; Gazi, L; Acharyya, S; Ide, S; Marker, M; Ottmann, O G.
Affiliation
  • Garcia-Manero G; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sekeres MA; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Egyed M; Kaposi Mor County Teaching Hospital, Kasposvár, Hungary.
  • Breccia M; Sapienza University, Rome, Italy.
  • Graux C; Mont-Godinne University Hospital, Yvoir, Belgium.
  • Cavenagh JD; Barts Health NHS Trust, London, UK.
  • Salman H; Augusta University, Augusta, GA, USA.
  • Illes A; University of Debrecen, Debrecen, Hungary.
  • Fenaux P; Hôpital Saint-Louis, Université Paris Diderot, Paris, France.
  • DeAngelo DJ; Dana-Farber Cancer Institute, Boston, MA, USA.
  • Stauder R; Innsbruck Medical University, Innsbruck, Austria.
  • Yee K; Princess Margaret Cancer Centre, Toronto, Canada.
  • Zhu N; University of Alberta Hospital, Edmonton, Canada.
  • Lee JH; Asan Medical Center, University of Ulsan, Seoul, South Korea.
  • Valcarcel D; Hospital Vall d'Hebrón, Barcelona, Spain.
  • MacWhannell A; The Royal Wolverhampton Hospitals NHS Trust, Wolverhampton, UK.
  • Borbenyi Z; University of Szeged, Szeged, Hungary.
  • Gazi L; Novartis Pharma AG, Basel, Switzerland.
  • Acharyya S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Ide S; Novartis Pharmaceuticals Corporation, Cambridge, MA, USA.
  • Marker M; Novartis Pharma S.A.S., Rueil-Malmaison, France.
  • Ottmann OG; Department of Haematology, School of Medicine, Cardiff University, Cardiff, UK.
Leukemia ; 31(12): 2799-2806, 2017 12.
Article in En | MEDLINE | ID: mdl-28546581

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myelomonocytic, Chronic / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myelomonocytic, Chronic / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Leukemia Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2017 Type: Article Affiliation country: United States